Annual Long Term Debt
$2.72 B
-$342.39 M-11.17%
December 28, 2024
Summary
- As of February 24, 2025, CRL annual long term debt is $2.72 billion, with the most recent change of -$342.39 million (-11.17%) on December 28, 2024.
- During the last 3 years, CRL annual long term debt has fallen by -$192.54 million (-6.60%).
- CRL annual long term debt is now -12.05% below its all-time high of $3.10 billion, reached on December 31, 2022.
Performance
CRL Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
N/A
December 28, 2024
Summary
- CRL quarterly long term debt is not available.
Performance
CRL Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
CRL Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.2% | - |
| 3 y3 years | -6.6% | - |
| 5 y5 years | +38.6% | - |
CRL Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.1% | at low | ||
| 5 y | 5-year | -12.1% | +38.6% | ||
| alltime | all time | -12.1% | >+9999.0% |
Charles River Laboratories International Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $2.72 B(-11.2%) | - |
| Sep 2024 | - | $2.76 B(-2.8%) |
| Jun 2024 | - | $2.84 B(-7.8%) |
| Mar 2024 | - | $3.08 B(+0.4%) |
| Dec 2023 | $3.07 B(-1.0%) | $3.07 B(+5.6%) |
| Sep 2023 | - | $2.90 B(-5.7%) |
| Jun 2023 | - | $3.08 B(-2.6%) |
| Mar 2023 | - | $3.16 B(+2.1%) |
| Dec 2022 | $3.10 B(+6.2%) | $3.10 B(-6.3%) |
| Sep 2022 | - | $3.31 B(-1.7%) |
| Jun 2022 | - | $3.36 B(+14.4%) |
| Mar 2022 | - | $2.94 B(+0.8%) |
| Dec 2021 | $2.92 B(+39.9%) | $2.92 B(-7.0%) |
| Sep 2021 | - | $3.14 B(+5.7%) |
| Jun 2021 | - | $2.97 B(+24.9%) |
| Mar 2021 | - | $2.38 B(+13.9%) |
| Dec 2020 | $2.09 B(+6.1%) | $2.09 B(-1.4%) |
| Sep 2020 | - | $2.11 B(-10.2%) |
| Jun 2020 | - | $2.35 B(-4.3%) |
| Mar 2020 | - | $2.46 B(+25.1%) |
| Dec 2019 | $1.97 B(+20.1%) | $1.97 B(-1.7%) |
| Sep 2019 | - | $2.00 B(-6.9%) |
| Jun 2019 | - | $2.15 B(+30.2%) |
| Mar 2019 | - | $1.65 B(+0.8%) |
| Dec 2018 | $1.64 B(+46.9%) | $1.64 B(-1.0%) |
| Sep 2018 | - | $1.65 B(-8.0%) |
| Jun 2018 | - | $1.80 B(+59.0%) |
| Mar 2018 | - | $1.13 B(+1.4%) |
| Dec 2017 | $1.11 B(-7.7%) | $1.11 B(-3.6%) |
| Sep 2017 | - | $1.16 B(+3.6%) |
| Jun 2017 | - | $1.12 B(-4.6%) |
| Mar 2017 | - | $1.17 B(-3.1%) |
| Dec 2016 | $1.21 B(+42.8%) | $1.21 B(-2.1%) |
| Sep 2016 | - | $1.23 B(-7.4%) |
| Jun 2016 | - | $1.33 B(+58.4%) |
| Mar 2016 | - | $840.48 M(-0.7%) |
| Dec 2015 | $846.00 M(+14.2%) | $846.00 M(+1.2%) |
| Sep 2015 | - | $835.80 M(+10.7%) |
| Jun 2015 | - | $754.78 M(+0.0%) |
| Mar 2015 | - | $754.53 M(+1.9%) |
| Dec 2014 | $740.56 M(+15.3%) | $740.56 M(-1.9%) |
| Sep 2014 | - | $754.80 M(-3.4%) |
| Jun 2014 | - | $781.62 M(+27.3%) |
| Mar 2014 | - | $614.13 M(-4.4%) |
| Dec 2013 | $642.35 M(+21.9%) | $642.35 M(+2.9%) |
| Sep 2013 | - | $624.31 M(+0.7%) |
| Jun 2013 | - | $619.77 M(+19.6%) |
| Mar 2013 | - | $518.03 M(-1.7%) |
| Dec 2012 | $527.14 M | $527.14 M(-2.9%) |
| Sep 2012 | - | $543.14 M(-1.5%) |
| Jun 2012 | - | $551.40 M(-18.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $674.74 M(-4.0%) |
| Dec 2011 | $703.19 M(+4.9%) | $703.19 M(-2.4%) |
| Sep 2011 | - | $720.48 M(-1.5%) |
| Jun 2011 | - | $731.42 M(-3.9%) |
| Mar 2011 | - | $761.29 M(+13.6%) |
| Dec 2010 | $670.27 M(+46.5%) | $670.27 M(-4.4%) |
| Sep 2010 | - | $701.08 M(+71.2%) |
| Jun 2010 | - | $409.44 M(-6.5%) |
| Mar 2010 | - | $437.91 M(-4.3%) |
| Dec 2009 | $457.42 M(-15.4%) | $457.42 M(-1.4%) |
| Sep 2009 | - | $463.75 M(-4.7%) |
| Jun 2009 | - | $486.49 M(+2.6%) |
| Mar 2009 | - | $474.15 M(-12.3%) |
| Dec 2008 | $540.65 M(+11.5%) | $540.65 M(+78.0%) |
| Sep 2008 | - | $303.68 M(-2.7%) |
| Jun 2008 | - | $312.26 M(-34.4%) |
| Mar 2008 | - | $476.37 M(-1.8%) |
| Dec 2007 | $485.00 M(-11.3%) | $485.00 M(-1.8%) |
| Sep 2007 | - | $493.70 M(-3.5%) |
| Jun 2007 | - | $511.82 M(-3.0%) |
| Mar 2007 | - | $527.55 M(-3.6%) |
| Dec 2006 | $547.08 M(+110.5%) | $547.08 M(-5.1%) |
| Sep 2006 | - | $576.54 M(+0.8%) |
| Jun 2006 | - | $571.81 M(+111.3%) |
| Mar 2006 | - | $270.65 M(+4.1%) |
| Dec 2005 | $259.90 M(-57.1%) | $259.90 M(-12.7%) |
| Sep 2005 | - | $297.73 M(-8.6%) |
| Jun 2005 | - | $325.68 M(-44.4%) |
| Mar 2005 | - | $585.77 M(-3.3%) |
| Dec 2004 | $605.98 M(+226.4%) | $605.98 M(+225.9%) |
| Sep 2004 | - | $185.96 M(-0.1%) |
| Jun 2004 | - | $186.14 M(-0.0%) |
| Mar 2004 | - | $186.23 M(+0.3%) |
| Dec 2003 | $185.68 M(-3.5%) | $185.68 M(-2.1%) |
| Sep 2003 | - | $189.76 M(-0.1%) |
| Jun 2003 | - | $189.87 M(+0.0%) |
| Mar 2003 | - | $189.85 M(-1.4%) |
| Dec 2002 | $192.48 M(+23.5%) | $192.48 M(+2.1%) |
| Sep 2002 | - | $188.59 M(-0.2%) |
| Jun 2002 | - | $189.05 M(-27.2%) |
| Mar 2002 | - | $259.52 M(+66.5%) |
| Dec 2001 | $155.87 M(-23.0%) | $155.87 M(-19.5%) |
| Sep 2001 | - | $193.65 M(-4.0%) |
| Jun 2001 | - | $201.71 M(-12.6%) |
| Mar 2001 | - | $230.71 M(+13.9%) |
| Dec 2000 | $202.50 M(-47.1%) | $202.50 M(-0.1%) |
| Sep 2000 | - | $202.78 M(-48.4%) |
| Jun 2000 | - | $393.36 M(+0.7%) |
| Mar 2000 | - | $390.46 M |
| Dec 1999 | $382.50 M(>+9900.0%) | - |
| Dec 1998 | $1.19 M | - |
FAQ
- What is Charles River Laboratories International annual long term debt?
- What is the all time high annual long term debt for Charles River Laboratories International?
- What is Charles River Laboratories International annual long term debt year-on-year change?
- What is the all time high quarterly long term debt for Charles River Laboratories International?
What is Charles River Laboratories International annual long term debt?
The current annual long term debt of CRL is $2.72 B
What is the all time high annual long term debt for Charles River Laboratories International?
Charles River Laboratories International all-time high annual long term debt is $3.10 B
What is Charles River Laboratories International annual long term debt year-on-year change?
Over the past year, CRL annual long term debt has changed by -$342.39 M (-11.17%)
What is the all time high quarterly long term debt for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly long term debt is $3.36 B